Trials / Recruiting
RecruitingNCT05855317
Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS
Association Between the Level of Extracellular Vesicle - Associated Tissue Factor and the Occurence of Pulmonary Embolism in Patients With Acute Respiratory Distress Syndrome
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 170 (estimated)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, 120 patients with Acute Respiratory Distress Syndrome (ARDS) will be included on a two years-period in an intensive care unit (Assistance Publique des Hôpitaux de Marseille, France). Those patients will benefit from a blood test at inclusion in order to measure several coagulation biomarkers, including EV-TF. Subsequently, these patients will be treated according to the usual practices of the department, following recommendations. Patients who received an injected CT scan between Day 5 and Day 28 will be divided into two groups based on the presence or absence of a pulmonary embolism on imaging. The measured values of EV-TF levels and other studied biomarkers will be compared between these two groups in order to detect a possible association between them and the diagnosis of pulmonary embolism. It should be noted that patients receiving an injected CT-scan between Day 5 and Day 7 will be included in the main analysis while those receiving it between Day 8 and Day 28 will be included in the secondary analysis. Others will be excluded from any analysis. At the same time, several collections of clinical data will be carried out: on Day 1, Day 7, Day 28, and on the day of the CT scan if it is performed at another time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sample | Additional blood samples will be taken on a catheter, used for standard care. |
Timeline
- Start date
- 2023-10-31
- Primary completion
- 2027-10-30
- Completion
- 2027-10-30
- First posted
- 2023-05-11
- Last updated
- 2026-02-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05855317. Inclusion in this directory is not an endorsement.